Antibody Gene Diversification by Aid-Catalyzed DNA Editing

RNA and DNA Editing: Molecular Mechanisms and Their Integration into Biological Systems

Volumn , Issue , 2007, Pages 31-70

  Macduff, Donna A ^a   Offer, Steven M ^a   Demorest, Zachary L ^a   Harris, Reuben S ^b  

^a Department of Biochemistry Molecular Biology and Biophysics ^*  (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Antigen binding domain; Antigen specific antibodies; Immunoglobulin gene conversion

Indexed keywords

EID: 84889402507     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470262269.ch2     Document Type: Chapter

References (207)

1. Watson, J. D., and Crick, F. H. (1953) Molecular structure of nucleic acids; a structure for deoxyribose nucleic acid. Nature 171, 737-738.
2. Franklin, R. E., and Gosling, R. G. (1953) Evidence for 2-chain helix in crystalline structure of sodium deoxyribonucleate. Nature 172, 156-157.
3. Jerne, N. K. (1955) The Natural-selection theory of antibody formation. Proc Natl Acad Sci USA 41, 849-857.
4. Burnet, F. (1957)Amodification of Jerne's theory on antibody production using the concept of clonal selection. Aust J Sci 20, 67-69.
5. Lederberg, J. (1959) Genes and antibodies. Science 129, 1649-1653.
6. White, R. G. (1958) Antibody production by single cells. Nature 182, 1383-1384.
7. Nossal, G. J., and Lederberg, J. (1958) Antibody production by single cells. Nature 181, 1419-1420.
8. Coons, A. H. (1957) The application of fluorescent antibodies to the study of naturally occurring antibodies. Ann NY Acad Sci 69, 658-662.
9. Brenner, S., and Milstein, C. (1966) Origin of antibody variation. Nature 211, 242-243.
10. Titani, K., and Putnam, F. W. (1965) Immunoglobulin structure: Amino-and carboxyl-terminal peptides of type I Bence-Jones proteins. Science 147, 1304-1305.
11. Putnam, F. W., and Easley, C. W. (1965) Structural studies of the immunoglobulins. I. The tryptic peptides of Bence-Jones proteins. J Biol Chem 240, 1626-1638.
12. Porter, R. R. (1958) Separation and isolation of fractions of rabbit gamma-globulin containing the antibody and antigenic combining sites. Nature 182, 670-671.
13. Milstein, C. (1966) Comparative peptide sequences of kappa and lambda chains of human immunoglobins. J Mol Biol 21, 203-205.
14. Milstein, C. (1966) Variations in amino-acid sequence near the disulphide bridges of Bence-Jones proteins. Nature 209, 370-373.
15. Hilschmann, N., and Craig, L. C. (1965)Aminoacid sequence studies with Bence-Jones proteins. Proc Natl Acad Sci USA 53, 1403-1409.
16. Cioli, D., and Baglioni, C. (1966) Origin of structural variation in Bence Jones proteins. J Mol Biol 15, 385-388.
17. Smithies, O. (1965) Disulfide-bond cleavage and formation in proteins. Science 150, 1595-1598.
18. Dreyer,W. J., and Bennett, J. C. (1965) The molecular basis of antibody formation: A paradox. Proc Natl Acad Sci USA 54, 864-869.
19. Burch, P. R., Burwell, R. G., and Rowell, N. R. (1965) Aetiology of multiple sclerosis. Br Med J 1, 723.
20. Hozumi, N., and Tonegawa, S. (1976) Evidence for somatic rearrangement of immunoglobulin genes coding for variable and constant regions. Proc Natl Acad Sci USA 73, 3628-3632.
21. Oettinger, M. A., Schatz, D. G., Gorka, C., and Baltimore, D. (1990) RAG-1 and RAG-2, adjacent genes that synergistically activate V(D)J recombination. Science 248, 1517-1523.
22. Schatz, D. G., Oettinger, M. A., and Baltimore, D. (1989) The V(D)J recombination activating gene. RAG-1. Cell 59, 1035-1048.
23. Jones, J. M., and Gellert, M. (2004) The taming of a transposon: V(D)J recombination and the immune system. Immunol Rev 200, 233-248.
24. Schatz, D. G. (1999) Transposition mediated by RAG1 and RAG2 and the evolution of the adaptive immune system. Immunol Res 19, 169-182.
25. Brandt, V. L., and Roth, D. B. (2004) V(D)J recombination: How to tame a transposase. Immunol Rev 200, 249-260.
26. Spicuglia, S., Franchini, D. M., and Ferrier, P. (2006) Regulation of V(D)J recombination. Curr Opin Immunol 18, 158-163.
27. Jung, D., Giallourakis, C., Mostoslavsky, R., and Alt, F.W. (2006) Mechanism and control of V(D)J recombination at the immunoglobulin heavy chain locus. Annu Rev Immunol 24, 541-570.
28. Lieber, M. R., Ma, Y., Pannicke, U., and Schwarz, K. (2004) The mechanism of vertebrate nonhomologous DNA end joining and its role in V(D)J recombination. DNA Repair (Amst) 3, 817-826.
29. Janeway, C. A., Travers, P., Walport, M., and Schlomchik, M. J. (2005) Immunobiology, 6th ed, Garland Science, New York.
30. Kohler, G., and Milstein, C. (1975) Continuous cultures of fused cells secreting antibody of predefined specificity. Nature 256, 495-497.
31. Cotton, R. G., and Milstein, C. (1973) Letter: Fusion of two immunoglobulin-producing myeloma cells. Nature 244, 42-43.
32. Sanger, F., and Tuppy, H. (1951) The amino-acid sequence in the phenylalanyl chain of insulin. 2. The investigation of peptides from enzymic hydrolysates., Biochem J 49, 481-490.
33. Wagner, S. D., and Neuberger, M. S. (1996) Somatic hypermutation of immunoglobulin genes. Annu Rev Immunol 14, 441-457.
34. Betz, A. G., Neuberger, M. S., and Milstein, C. (1993) Discriminating intrinsic and antigen-selected mutational hotspots in immunoglobulin V genes. Immunol Today 14, 405-411.
35. Weiss, U., and Rajewsky, K. (1990) The repertoire of somatic antibody mutants accumulating in the memory compartment after primary immunization is restricted through affinity maturation and mirrors that expressed in the secondary response. J Exp Med 172, 1681-1689.
36. Weigert, M. G., Cesari, I. M., Yonkovich, S. J., and Cohn, M. (1970) Variability in the lambda light chain sequences of mouse antibody. Nature 228, 1045-1047.
37. Betz, A. G., Rada, C., Pannell, R., Milstein, C., and Neuberger, M. S. (1993) Passenger transgenes reveal intrinsic specificity of the antibody hypermutation mechanism: Clustering, polarity, and specific hot spots. Proc Natl Acad Sci USA 90, 2385-2388.
38. Berek, C., and Milstein, C. (1987) Mutation drift and repertoire shift in the maturation of the immune response. Immunol Rev 96, 23-41.
39. Sarvas, H., and Makela, O. (1970) Haptenated bacteriophage in the assay of antibody quantity and affinity: Maturation of an immune response. Immunochemistry 7, 933-943.
40. Maizels, N. (2005) Immunoglobulin gene diversification. Annu Rev Genet 39, 23-46.
41. Arakawa, H., and Buerstedde, J. M. (2004) Immunoglobulin gene conversion: Insights from bursal B cells and the DT40 cell line. Dev Dyn 229, 458-464.
42. Thompson, C. B., and Neiman, P. E. (1987) Somatic diversification of the chicken immunoglobulin light chain gene is limited to the rearranged variable gene segment. Cell 48, 369-378.
43. Reynaud, C. A., Anquez,V., Dahan, A., andWeill, J. C. (1985)Asingle rearrangement event generates most of the chicken immunoglobulin light chain diversity. Cell 40, 283-291.
44. Reynaud, C. A., Anquez, V., Grimal, H., and Weill, J. C. (1987) A hyperconversion mechanism generates the chicken light chain preimmune repertoire. Cell 48, 379-388.
45. Sale, J. E. (2004) Immunoglobulin diversification in DT40: A model for vertebrate DNA damage tolerance. DNA Repair (Amst) 3, 693-702.
46. Sonoda, E., Morrison, C.,Yamashita,Y. M., Takata, M., and Takeda, S. (2001) Reverse genetic studies of homologous DNArecombination using the chicken B-lymphocyte line, DT40. Philos Trans R Soc Lond B Biol Sci 356, 111-117.
47. Agarwal, S. C. (1964) Nomenclature for human immunoglobulins. Bull World Health Organ 30, 447-450.
48. Maki, R., Traunecker, A., Sakano, H., Roeder,W., and Tonegawa, S. (1980) Exon shuffling generates an immunoglobulin heavy chain gene. Proc Natl Acad Sci USA 77, 2138-2142.
49. Kataoka, T., Kawakami, T., Takahashi, N., and Honjo, T. (1980) Rearrangement of immunoglobulin gamma 1-chain gene and mechanism for heavy-chain class switch. Proc Natl Acad Sci USA 77, 919-923.
50. Davis, M. M., Calame, K., Early, P.W., Livant, D. L., Joho, R.,Weissman, I. L., and Hood, L. (1980)An immunoglobulin heavy-chain gene is formed by at least two recombinational events. Nature 283, 733-739.
51. Muramatsu, M., Sankaranand, V. S., Anant, S., Sugai, M., Kinoshita, K., Davidson, N. O., and Honjo, T. (1999) Specific expression of activation-induced cytidine deaminase (AID), a novel member of the RNA-editing deaminase family in germinal center B cells. J Biol Chem 274, 18470-18476.
52. Muto, T., Muramatsu, M., Taniwaki, M., Kinoshita, K., and Honjo, T. (2000) Isolation, tissue distribution, and chromosomal localization of the human activation-induced cytidine deaminase (AID) gene. Genomics 68, 85-88.
53. Muramatsu, M., Kinoshita, K., Fagarasan, S., Yamada, S., Shinkai, Y., and Honjo, T. (2000) Class switch recombination and hypermutation require activation-induced cytidine deaminase (AID), a potential RNA editing enzyme. Cell 102, 553-563.
54. Revy,P., Muto,T., Levy,Y., Geissmann,F., Plebani, A., Sanal, O., Catalan, N., Forveille, M., Dufourcq-Labelouse, R., Gennery, A.,Tezcan, I., Ersoy, F., Kayserili, H., Ugazio, A. G., Brousse, N., Muramatsu, M., Notarangelo, L. D., Kinoshita, K., Honjo,T., Fischer, A., and Durandy, A. 2000 Activation-induced cytidine deaminase (AID) deficiency causes the autosomal recessive form of the Hyper-IgM syndrome (HIGM2). Cell 102 565-575.
55. Harris, R. S., Sale, J. E., Petersen-Mahrt, S. K., and Neuberger, M. S. (2002) AID is essential for immunoglobulin V gene conversion in a cultured B cell line. Curr Biol 12, 435-438.
56. Arakawa, H., Hauschild, J., and Buerstedde, J. M. (2002) Requirement of the activation-induced deaminase (AID) gene for immunoglobulin gene conversion. Science 295, 1301-1306.
57. Kinoshita, K., and Honjo, T. (2001) Linking class-switch recombination with somatic hypermutation. Nat Rev Mol Cell Biol 2, 493-503.
58. Dickerson, S. K., Market, E., Besmer, E., and Papavasiliou, F. N. (2003) AID mediates hypermutation by deaminating single stranded DNA. J Exp Med 197, 1291-1296.
59. Bransteitter, R., Pham, P., Scharff, M. D., and Goodman, M. F. (2003) Activation-induced cytidine deaminase deaminates deoxycytidine on single-strandedDNAbut requires the action of RNase. Proc Natl Acad Sci USA 100, 4102-4107.
60. Doi, T., Kinoshita, K., Ikegawa, M., Muramatsu, M., and Honjo,T. (2003) De novo protein synthesis is required for the activation-induced cytidine deaminase function in class-switch recombination. Proc Natl Acad Sci USA 100, 2634-2638.
61. Nagaoka, H., Ito, S., Muramatsu, M., Nakata, M., and Honjo, T. (2005) DNA cleavage in immunoglobulin somatic hypermutation depends on de novo protein synthesis but not on uracil DNA glycosylase. Proc Natl Acad Sci USA 102, 2022-2027.
62. Begum, N. A., Kinoshita, K., Muramatsu, M., Nagaoka, H., Shinkura, R., and Honjo, T. (2004) De novo protein synthesis is required for activation-induced cytidine deaminase-dependent DNA cleavage in immunoglobulin class switch recombination. Proc Natl Acad Sci USA 101, 13003-13007.
63. Neuberger, M. S., and Scott, J. (2000) Immunology. RNA editing AIDs antibody diversification? Science 289, 1705-1706.
64. Jacobs, H., and Bross, L. (2001) Towards an understanding of somatic hypermutation. Curr Opin Immunol 13, 208-218.
65. Martin, A., Bardwell, P. D., Woo, C. J., Fan, M., Shulman, M. J., and Scharff, M. D. (2002) Activation-induced cytidine deaminase turns on somatic hypermutation in hybridomas. Nature 415, 802-806.
66. Petersen-Mahrt, S. K., Harris, R. S., and Neuberger, M. S. (2002) AID mutates E. coli suggesting a DNA deamination mechanism for antibody diversification. Nature 418, 99-103.
67. Chaudhuri, J.,Tian, M., Khuong, C., Chua, K., Pinaud, E., and Alt, F.W. (2003)Transcription-targeted DNA deamination by the AID antibody diversification enzyme. Nature 422, 726-730.
68. Wiesendanger, M., Kneitz, B., Edelmann, W., and Scharff, M. D. (2000) Somatic hypermutation in MutS homologue (MSH)3-, MSH6-, and MSH3/MSH6-deficient mice reveals a role for the MSH2-MSH6 heterodimer in modulating the base substitution pattern. J Exp Med 191, 579-584.
69. Rada, C., Ehrenstein, M. R., Neuberger, M. S., and Milstein, C. (1998) Hot spot focusing of somatic hypermutation in MSH2-deficient mice suggests two stages of mutational targeting. Immunity 9, 135-141.
70. Di Noia, J., and Neuberger, M. S. (2002) Altering the pathway of immunoglobulin hypermutation by inhibiting uracil-DNA glycosylase. Nature 419, 43-48.
71. Rada, C., Williams, G. T., Nilsen, H., Barnes, D. E., Lindahl, T., and Neuberger, M. S. (2002) Immunoglobulin isotype switching is inhibited and somatic hypermutation perturbed in UNGdeficient mice. Curr Biol 12, 1748-1755.
72. Imai, K., Slupphaug, G., Lee, W. I., Revy, P., Nonoyama, S., Catalan, N., Yel, L., Forveille, M., Kavli, B., Krokan, H. E., et al. (2003) Human uracil-DNA glycosylase deficiency associated with profoundly impaired immunoglobulin class-switch recombination. Nat Immunol 4, 1023-1028.
73. Begum, N. A., Kinoshita, K., Kakazu, N., Muramatsu, M., Nagaoka, H., Shinkura, R., Biniszkiewicz, D., Boyer, L. A., Jaenisch, R., and Honjo, T. (2004) UracilDNAglycosylase activity is dispensable for immunoglobulin class switch. Science 305, 1160-1163.
74. Stivers, J.T. (2004)Commenton "UracilDNAglycosylase activity is dispensable for immunoglobulin class switch." Science 306, 2042; author reply 2042.
75. Scaramozzino, N., Sanz, G., Crance, J. M., Saparbaev, M., Drillien, R., Laval, J., Kavli, B., and Garin, D. (2003) Characterisation of the substrate specificity of homogeneous vaccinia virus uracil-DNA glycosylase. Nucleic Acids Res 31, 4950-4957.
76. Drohat, A. C., Jagadeesh, J., Ferguson, E., and Stivers, J. T. (1999) Role of electrophilic and general base catalysis in the mechanism of Escherichia coli uracil DNA glycosylase. Biochemistry 38, 11866-11875.
77. Mol, C. D., Arvai, A. S., Slupphaug, G., Kavli, B., Alseth, I., Krokan, H. E., and Tainer, J. A. (1995) Crystal structure and mutational analysis of human uracil-DNA glycosylase: Structural basis for specificity and catalysis. Cell 80, 869-878.
78. Rada, C., Di Noia, J. M., and Neuberger, M. S. (2004) Mismatch recognition and uracil excision provide complementary paths to both Ig switching and the A/T-focused phase of somatic mutation. Mol Cell 16, 163-171.
79. Di Noia, J. M., Rada, C., and Neuberger, M. S. (2006) SMUG1 is able to excise uracil from immunoglobulin genes: Insight into mutation versus repair. EMBO J 25, 585-595.
80. Rajewsky, K., Forster, I., and Cumano, A. (1987) Evolutionary and somatic selection of the antibody repertoire in the mouse. Science 238, 1088-1094.
81. Kim, S., Davis, M., Sinn, E., Patten, P., and Hood, L. (1981) Antibody diversity: Somatic hypermutation of rearranged VH genes. Cell 27, 573-581.
82. Xue, K., Rada, C., and Neuberger,M.S. (2006)The invivo pattern ofAIDtargeting toimmunoglobulin switch regions deduced from mutation spectra in msh2-/- ung-/- mice. J Exp Med 203, 2085-2094.
83. Ross, A. L., and Sale, J. E. (2006) The catalytic activity of REV1 is employed during immunoglobulin gene diversification in DT40. Mol Immunol 43, 1587-1594.
84. Zan, H., Shima, N., Xu, Z., Al-Qahtani, A., Evinger, A. J., III Zhong,Y., Schimenti, J. C., and Casali, P. (2005) The translesionDNApolymerase theta plays a dominant role in immunoglobulin gene somatic hypermutation. EMBO J 24, 3757-3769.
85. Simpson, L. J., and Sale, J. E. (2003) Rev1 is essential for DNA damage tolerance and non-templated immunoglobulin gene mutation in a vertebrate cell line. EMBO J 22, 1654-1664.
86. Zan, H.,Komori, A., Li, Z., Cerutti, A., Schaffer, A., Flajnik, M. F., Diaz, M., and Casali, P. (2001) The translesionDNApolymerase zeta plays a major role in Ig and Bcl-6 somatic hypermutation. Immunity 14, 643-653.
87. Diaz, M., Verkoczy, L. K., Flajnik, M. F., and Klinman, N. R. (2001) Decreased frequency of somatic hypermutation and impaired affinity maturation but intact germinal center formation in mice expressing antisense RNA to DNA polymerase zeta. J Immunol 167, 327-335.
88. Martomo, S. A., Yang, W. W., Vaisman, A., Maas, A., Yokoi, M., Hoeijmakers, J. H., Hanaoka, F., Woodgate, R., and Gearhart, P. J. (2006) Normal hypermutation in antibody genes from congenic mice defective for DNA polymerase iota. DNA Repair (Amst) 5, 392-398.
89. Shimizu, T., Azuma, T., Ishiguro, M., Kanjo, N., Yamada, S., and Ohmori, H. (2005) Normal immunoglobulin gene somatic hypermutation in Pol kappa-Pol iota double-deficient mice. Immunol Lett 98, 259-264.
90. Arakawa, H., Moldovan, G. L., Saribasak, H., Saribasak, N. N., Jentsch, S., and Buerstedde, J. M. (2006) A role for PCNA ubiquitination in immunoglobulin hypermutation. PLoS Biol 4, e366.
91. Zeng, X.,Winter, D. B., Kasmer, C., Kraemer, K. H., Lehmann, A. R., and Gearhart, P. J. (2001)DNA polymerase eta is an A-T mutator in somatic hypermutation of immunoglobulin variable genes. Nat Immunol 2, 537-541.
92. Delbos, F., De Smet, A., Faili, A., Aoufouchi, S.,Weill, J. C., and Reynaud, C. A. (2005) Contribution of DNA polymerase eta to immunoglobulin gene hypermutation in the mouse. J Exp Med 201, 1191-1196.
93. Delbos, F., Aoufouchi, S., Faili, A.,Weill, J. C., and Reynaud, C. A. (2007)DNApolymerase eta is the sole contributor of A/T modifications during immunoglobulin gene hypermutation in the mouse. J Exp Med 204, 17-23.
94. Shen, H. M., Tanaka, A., Bozek, G., Nicolae, D., and Storb, U. (2006) Somatic hypermutation and class switch recombination in Msh6(-/-)Ung(-/-) double-knockout mice. J Immunol 177, 5386-5392.
95. Bardwell, P. D., Woo, C. J., Wei, K., Li, Z., Martin, A., Sack, S. Z., Parris, T., Edelmann, W., and Scharff, M. D. (2004) Altered somatic hypermutation and reduced class-switch recombination in exonuclease 1-mutant mice. Nat Immunol 5, 224-229.
96. Wu, X., Tsai, C.Y., Patam, M. B., Zan, H., Chen, J. P., Lipkin, S. M., and Casali, P. (2006)Arole for the MutL mismatch repair Mlh3 protein in immunoglobulin class switchDNArecombination and somatic hypermutation. J Immunol 176, 5426-5437.
97. Li, Z., Peled, J. U., Zhao, C., Svetlanov, A., Ronai, D., Cohen, P. E., and Scharff, M. D. (2006)Arole for Mlh3 in somatic hypermutation. DNA Repair (Amst) 5, 675-682.
98. Ehrenstein, M. R., Rada, C., Jones, A. M., Milstein, C., and Neuberger, M. S. (2001) Switch junction sequences in PMS2-deficient mice reveal a microhomology-mediated mechanism of Ig class switch recombination. Proc Natl Acad Sci USA 98, 14553-14558.
99. Phung, Q. H.,Winter, D. B., Alrefai, R., and Gearhart, P. J. (1999) Hypermutation in Ig V genes from mice deficient in the MLH1 mismatch repair protein. J Immunol 162, 3121-3124.
100. Kong, Q., and Maizels, N. (1999) PMS2-deficiency diminishes hypermutation of a lambda1 transgene in young but not older mice. Mol Immunol 36, 83-91.
101. Saribasak, H., Saribasak, N. N., Ipek, F. M., Ellwart, J.W., Arakawa, H., and Buerstedde, J. M. (2006) Uracil DNA glycosylase disruption blocks Ig gene conversion and induces transition mutations. J Immunol 176, 365-371.
102. Di Noia, J. M., and Neuberger, M. S. (2004) Immunoglobulin gene conversion in chicken DT40 cells largely proceeds through an abasic site intermediate generated by excision of the uracil produced by AID-mediated deoxycytidine deamination. Eur J Immunol 34, 504-508.
103. Yabuki, M., Fujii, M. M., and Maizels, N. (2005) The MRE11-RAD50-NBS1 complex accelerates somatic hypermutation and gene conversion of immunoglobulin variable regions. Nat Immunol 6, 730-736.
104. Larson, E. D., Cummings,W. J., Bednarski, D. W., and Maizels, N. (2005) MRE11/RAD50 cleaves DNA in the AID/UNG-dependent pathway of immunoglobulin gene diversification. Mol Cell 20, 367-375.
105. Reina-San-Martin, B., Nussenzweig,M.C., Nussenzweig, A., and Difilippantonio, S. (2005) Genomic instability, endoreduplication, and diminished Ig class-switch recombination in B cells lacking Nbs1. Proc Natl Acad Sci USA 102, 1590-1595.
106. Sale, J. E., Calandrini, D. M.,Takata, M.,Takeda, S., and Neuberger, M. S. (2001) Ablation ofXRCC2/3 transforms immunoglobulin V gene conversion into somatic hypermutation. Nature 412, 921-926.
107. Hatanaka, A.,Yamazoe, M., Sale, J. E., Takata, M.,Yamamoto, K., Kitao, H., Sonoda, E., Kikuchi, K., Yonetani, Y., and Takeda, S. (2005) Similar effects of Brca2 truncation and Rad51 paralog deficiency on immunoglobulin V gene diversification in DT40 cells support an early role for Rad51 paralogs in homologous recombination. Mol Cell Biol 25, 1124-1134.
108. Cook, A. J., Raftery, J. M., Lau, K. K., Jessup, A., Harris, R. S., Takeda, S., and Jolly, C. J. (2007) DNA-dependent protein kinase inhibits AID-induced antibody gene conversion. PLoS Biol 5, e80.
109. Tang, E. S., and Martin, A. (2006) NHEJ-deficient DT40 cells have increased levels of immunoglobulin gene conversion: Evidence for a double strand break intermediate. Nucleic Acids Res 34, 6345-6351.
110. Etzioni, A., and Ochs, H. D. (2004) The hyper IgM syndrome-an evolving story. Pediatr Res 56, 519-525.
111. Kadyrov, F. A., Dzantiev, L., Constantin, N., and Modrich, P. (2006) Endonucleolytic function of MutLalpha in human mismatch repair. Cell 126, 297-308.
112. Schrader, C. E., Edelmann, W., Kucherlapati, R., and Stavnezer, J. (1999) Reduced isotype switching in splenic B cells from mice deficient in mismatch repair enzymes. J Exp Med 190, 323-330.
113. Schrader, C. E.,Vardo, J., and Stavnezer, J. (2002) Role for mismatch repair proteins Msh2, Mlh1, and Pms2 in immunoglobulin class switching shown by sequence analysis of recombination junctions. J Exp Med 195, 367-373.
114. Tauchi, H.,Kobayashi, J., Morishima, K., van Gent, D. C., Shiraishi, T.,Verkaik, N. S., vanHeems, D., Ito, E., Nakamura, A., Sonoda, E., Takata, M., Takada, S., Matsuura, S., andKomatsu, K. (2002) Nbs1 is essential for DNA repair by homologous recombination in higher vertebrate cells. Nature 420, 93-98.
115. Grenon, M., Gilbert, C., and Lowndes, N. F. (2001) Checkpoint activation in response to double-strand breaks requires the Mre11/Rad50/Xrs2 complex. Nat Cell Biol 3, 844-847.
116. de Jager, M., Dronkert, M. L., Modesti, M., Beerens, C. E., Kanaar, R., and van Gent, D. C. (2001) DNA-binding and strand-annealing activities of human Mre11: Implications for its roles in DNA double-strand break repair pathways. Nucleic Acids Res 29, 1317-1325.
117. Buscemi, G., Savio, C., Zannini, L., Micciche, F., Masnada, D., Nakanishi, M., Tauchi, H., Komatsu, K., Mizutani, S., Khanna, K., Chen, P., Concannon,P., Chessa, L., and Delia, D. (2001) Chk2 activation dependence on Nbs1 after DNA damage. Mol Cell Biol 21, 5214-5222.
118. Stewart, G. S., Maser, R. S., Stankovic, T., Bressan, D. A., Kaplan, M. I., Jaspers, N. G., Raams, A., Byrd, P. J., Petrini, J. H., and Taylor, A. M. (1999) TheDNAdouble-strand break repair gene hMRE11 is mutated in individuals with an ataxia-telangiectasia-like disorder. Cell 99, 577-587.
119. Varon, R., Vissinga, C., Platzer, M., Cerosaletti, K. M., Chrzanowska, K. H., Saar, K., Beckmann, G., Seemanova, E., Cooper, P. R., Nowak, N. J., Stumm, M., Weemaes, C. M., Gatti, R. A., Wilson, R. K., Digweed, M., Rosenthal, A., Sperling, K., Concannon, P., and Reis, A. 1998 Nibrin, a novel DNA double-strand break repair protein, is mutated in Nijmegen breakage syndrome. Cell 93, 467-476.
120. Carney, J. P., Maser, R. S., Olivares, H., Davis, E. M., Le Beau, M., Yates, J. R., 3rd Hays, L., Morgan, W. F., and Petrini, J. H. (1998) The hMre11/hRad50 protein complex and Nijmegen breakage syndrome: Linkage of double-strand break repair to the cellular DNA damage response. Cell 93 477-486.
121. Lahdesmaki, A.,Taylor, A. M., Chrzanowska, K. H., and Pan-Hammarstrom, Q. (2004) Delineation of the role of the Mre11 complex in class switch recombination. J Biol Chem 279, 16479-16487.
122. Zhu, J., Petersen, S., Tessarollo, L., and Nussenzweig, A. (2001) Targeted disruption of the Nijmegen breakage syndrome gene NBS1 leads to early embryonic lethality in mice. Curr Biol 11, 105-109.
123. Luo, G., Yao, M. S., Bender, C. F., Mills, M., Bladl, A. R., Bradley, A., and Petrini, J. H. (1999) Disruption of mRad50 causes embryonic stem cell lethality, abnormal embryonic development, and sensitivity to ionizing radiation. Proc Natl Acad Sci USA 96, 7376-7381.
124. Xiao, Y., and Weaver, D. T. (1997) Conditional gene targeted deletion by Cre recombinase demonstrates the requirement for the double-strand break repair Mre11 protein in murine embryonic stem cells. Nucleic Acids Res 25, 2985-2991.
125. Kracker, S., Bergmann, Y., Demuth, I., Frappart, P. O., Hildebrand, G., Christine, R., Wang, Z. Q., Sperling, K., Digweed, M., and Radbruch, A. (2005) Nibrin functions in Ig class-switch recombination. Proc Natl Acad Sci USA 102, 1584-1589.
126. Martin, A., Li, Z., Lin, D. P., Bardwell, P. D., Iglesias-Ussel, M. D., Edelmann,W., and Scharff, M. D. (2003) Msh2ATPase activity is essential for somatic hypermutation at A-T basepairs and for efficient class switch recombination. J Exp Med 198, 1171-1178.
127. Schrader, C. E., Vardo, J., and Stavnezer, J. (2003) Mlh1 can function in antibody class switch recombination independently of Msh2. J Exp Med 197, 1377-1383.
128. Li, Z., Scherer, S. J., Ronai, D., Iglesias-Ussel, M.D., Peled, J. U., Bardwell,P. D., Zhuang, M., Lee, K., Martin, A., Edelmann,W., and Scharff, M. D. (2004) Examination of Msh6-and Msh3-deficient mice in class switching reveals overlapping and distinct roles of MutS homologues in antibody diversification. J Exp Med 200, 47-59.
129. Martomo, S. A., Yang, W. W., and Gearhart, P. J. (2004) A role for Msh6 but not Msh3 in somatic hypermutation and class switch recombination. J Exp Med 200, 61-68.
130. Ehrenstein, M. R., and Neuberger, M. S. (1999) Deficiency in Msh2 affects the efficiency and local sequence specificity of immunoglobulin class-switch recombination: Parallels with somatic hypermutation. EMBO J 18, 3484-3490.
131. Sekine, H., Ferreira, R. C., Pan-Hammarstrom, Q., Graham, R. R., Ziemba, B., de Vries, S. S., Liu, J., Hippen, K.,Koeuth, T., Ortmann,W., Iwahori, A., Elliott, M. K., Offer, S., Skon, C., Du, L., Novitzke, J., Lee, A. T., Zhao, N., Tompkins, J. D., Altshuler, D., Gregersen, P. K., Cunningham-Rundles, C., Harris, R. S., Her, C., Nelson, D. L., Hammarstrom, L., Gilkeson, G. S., and Behrens, T.W. 2007 Role for Msh5 in the regulation of Ig class switch recombination. Proc Natl Acad Sci USA 104, 7193-7198.
132. Anderson, L., Henderson, C., and Adachi, Y. (2001) Phosphorylation and rapid relocalization of 53BP1 to nuclear foci upon DNA damage. Mol Cell Biol 21, 1719-1729.
133. Pan-Hammarstrom, Q., Dai, S., Zhao, Y., van Dijk-Hard, I. F., Gatti, R. A., Borresen-Dale, A. L., and Hammarstrom, L. (2003)ATMis not required in somatic hypermutation of VH, but is involved in the introduction of mutations in the switch mu region. J Immunol 170, 3707-3716.
134. Reina-San-Martin, B., Difilippantonio, S., Hanitsch, L., Masilamani, R. F., Nussenzweig, A., and Nussenzweig, M. C. (2003) H2AX is required for recombination between immunoglobulin switch regions but not for intra-switch region recombination or somatic hypermutation. J Exp Med 197, 1767-1778.
135. Manis, J. P., Morales, J. C., Xia, Z., Kutok, J. L., Alt, F.W., and Carpenter, P. B. (2004) 53BP1 links DNA damage-response pathways to immunoglobulin heavy chain class-switch recombination. Nat Immunol 5, 481-487.
136. Ward, I. M., Reina-San-Martin, B., Olaru, A., Minn, K.,Tamada, K., Lau, J. S., Cascalho, M., Chen, L., Nussenzweig, A., and Livak, F. et al. (2004) 53BP1 is required for class switch recombination. J Cell Biol 165, 459-464.
137. Manis, J. P., Gu, Y., Lansford, R., Sonoda, E., Ferrini, R., Davidson, L., Rajewsky, K., and Alt, F.W. (1998)Ku70 is required for lateBcell development and immunoglobulin heavy chain class switching. J Exp Med 187, 2081-2089.
138. Casellas, R., Nussenzweig, A.,Wuerffel, R., Pelanda, R., Reichlin, A., Suh, H., Qin, X. F., Besmer, E., Kenter, A., Rajewsky, K., and Nussenzweig, M. C. (1998) Ku80 is required for immunoglobulin isotype switching. EMBO J 17, 2404-2411.
139. Manis, J. P., Dudley, D., Kaylor, L., and Alt, F.W. (2002) IgH class switch recombination to IgG1 in DNA-PKcs-deficient B cells. Immunity 16, 607-617.
140. Cook, A. J., Oganesian, L., Harumal, P., Basten, A., Brink, R., and Jolly, C. J. (2003) Reduced switching in SCID B cells is associated with altered somatic mutation of recombined S regions. J Immunol 171, 6556-6564.
141. Bosma, G. C., Kim, J., Urich, T., Fath, D. M., Cotticelli, M. G., Ruetsch, N. R., Radic, M. Z., and Bosma, M. J. (2002)DNA-dependent protein kinase activity is not required for immunoglobulin class switching. J Exp Med 196, 1483-1495.
142. Kiefer, K., Oshinsky, J., Kim, J., Nakajima, P. B., Bosma, G. C., and Bosma, M. J. (2007) The catalytic subunit of DNA-protein kinase (DNA-PKcs) is not required for Ig class-switch recombination. Proc Natl Acad Sci USA 104, 2843-2848.
143. Gao, Y., Sun, Y., Frank, K. M., Dikkes, P., Fujiwara, Y., Seidl, K. J., Sekiguchi, J. M., Rathbun, G. A., Swat, W., Wang, J., Bronson, R. T., Maylynn, B. A., Bryans, M., Zhu, C., Chaudhuri, J., Davidson, L., Ferrini, R., Stamato, T., Orkin, S. H., Greenberg, M. E., and Alt, F. W. (1998) A critical role for DNA end-joining proteins in both lymphogenesis and neurogenesis. Cell 95 891-902.
144. Frank, K. M., Sekiguchi, J. M., Seidl, K. J., Swat, W., Rathbun, G. A., Cheng, H. L., Davidson, L., Kangaloo, L., and Alt, F. W. (1998) Late embryonic lethality and impaired V(D)J recombination in mice lacking DNA ligase IV. Nature 396, 173-177.
145. Nick McElhinny, S. A., Snowden, C. M., McCarville, J., and Ramsden, D. A. (2000) Ku recruits the XRCC4-ligase IV complex to DNA ends. Mol Cell Biol 20, 2996-3003.
146. Lee, K. J., Huang, J., Takeda, Y., and Dynan,W. S. (2000) DNA ligase IVand XRCC4 form a stable mixed tetramer that functions synergistically with other repair factors in a cell-free end-joining system. J Biol Chem 275, 34787-34796.
147. Chen, L., Trujillo, K., Sung, P., and Tomkinson, A. E. (2000) Interactions of the DNA ligase IVXRCC4 complex with DNA ends and the DNA-dependent protein kinase. J Biol Chem 275, 26196-26205.
148. Bryans, M., Valenzano, M. C., and Stamato, T. D. (1999) Absence of DNA ligase IV protein in XR-1 cells: Evidence for stabilization by XRCC4. Mutat Res 433, 53-58.
149. Rooney, S., Alt, F.W., Sekiguchi, J., and Manis, J. P. (2005) Artemis-independent functions of DNAdependent protein kinase in Ig heavy chain class switch recombination and development. Proc Natl Acad Sci USA 102, 2471-2475.
150. Buck, D., Malivert, L., de Chasseval, R., Barraud, A., Fondaneche, M. C., Sanal, O., Plebani, A., Stephan, J. L., Hufnagel, M., le Deist, F., et al. (2006) Cernunnos, a novel nonhomologous end-joining factor, is mutated in human immunodeficiency with microcephaly. Cell 124, 287-299.
151. Ahnesorg, P., Smith, P., and Jackson, S. P. (2006) XLF interacts with the XRCC4-DNA ligase IV complex to promote DNA nonhomologous end-joining. Cell 124, 301-313.
152. Lu, H., Pannicke, U., Schwarz, K., and Lieber, M. R. (2007) Length-dependent binding of humanXLF to DNA and stimulation of XRCC4/DNA ligase IV activity. J Biol Chem 282, 11155-11162.
153. Erdos, M., Durandy, A., and Marodi, L. (2005) Genetically acquired class-switch recombination defects: The multi-faced hyper-IgM syndrome. Immunol Lett 97, 1-6.
154. Durandy, A., Peron, S., and Fischer, A. (2006) Hyper-IgM syndromes. Curr Opin Rheumatol 18, 369-376.
155. Padayachee, M., Levinsky, R. J., Kinnon, C., Finn, A., McKeown, C., Feighery, C., Notarangelo, L. D., Hendriks, R.W., Read, A.P., and Malcolm, S. (1993)Mappingof theXlinked form of hyperIgM syndrome (HIGM1). J Med Genet 30, 202-205.
156. Padayachee, M., Feighery, C., Finn, A., McKeown, C., Levinsky, R. J., Kinnon, C., and Malcolm, S. (1992) Mapping of the X-linked form of hyper-IgM syndrome (HIGM1) to Xq26 by close linkage to HPRT. Genomics 14, 551-553.
157. Ferrari, S., Giliani, S., Insalaco, A., Al-Ghonaium, A., Soresina, A. R., Loubser, M., Avanzini, M. A., Marconi, M., Badolato, R., Ugazio, A. G., Levy,Y., Catalan, N., Durandy, A., Tbakhi, A., Notarangelo, L. D., and Plebani, A. (2001) Mutations of CD40 gene cause an autosomal recessive form of immunodeficiency with hyper IgM. Proc Natl Acad Sci USA 98, 12614-12619.
158. Jain, A., Ma, C. A., Liu, S., Brown, M., Cohen, J., and Strober,W. (2001) Specific missense mutations in NEMO result in hyper-IgM syndrome with hypohydrotic ectodermal dysplasia. Nat Immunol 2, 223-228.
159. Xie, K., Sowden, M. P., Dance, G. S., Torelli, A. T., Smith, H. C., and Wedekind, J. E. (2004) The structure of a yeast RNA-editing deaminase provides insight into the fold and function of activationinduced deaminase and APOBEC-1. Proc Natl Acad Sci USA 101, 8114-8119.
160. Ta, V. T., Nagaoka, H., Catalan, N., Durandy, A., Fischer, A., Imai, K., Nonoyama, S., Tashiro, J., Ikegawa, M., Ito, S., Kinoshita, K., Muramatsu, M., and Honjo,T. (2003)AIDmutant analyses indicate requirement for class-switch-specific cofactors. Nat Immunol 4, 843-848.
161. Imai, K., Zhu,Y., Revy, P., Morio, T., Mizutani, S., Fischer, A., Nonoyama, S., and Durandy, A. (2005) Analysis of class switch recombination and somatic hypermutation in patients affected with autosomal dominant hyper-IgM syndrome type 2. Clin Immunol 115, 277-285.
162. Shinkura, R., Ito, S., Begum, N. A., Nagaoka, H., Muramatsu, M., Kinoshita, K., Sakakibara, Y., Hijikata, H., and Honjo, T. (2004) Separate domains of AID are required for somatic hypermutation and class-switch recombination. Nat Immunol 5, 707-712.
163. Barreto, V., Reina-San-Martin, B., Ramiro, A. R., McBride, K. M., and Nussenzweig, M. C. (2003) C-terminal deletion of AID uncouples class switch recombination from somatic hypermutation and gene conversion. Mol Cell 12, 501-508.
164. Salzer, U., and Grimbacher, B. (2006) Common variable immunodeficiency: The power of costimulation. Semin Immunol 18, 337-346.
165. Castigli, E., and Geha, R. S. (2006) Molecular basis of commonvariable immunodeficiency. J Allergy Clin Immunol 117, 740-746.
166. Imai, K., Catalan, N., Plebani, A., Marodi, L., Sanal, O.,Kumaki, S., Nagendran,V.,Wood, P., Glastre, C., Sarrot-Reynauld, F. et al. (2003) Hyper-IgM syndrome type 4 with a B lymphocyte-intrinsic selective deficiency in Ig class-switch recombination. J Clin Invest 112, 136-142.
167. Vorechovsky, I., Zetterquist, H., Paganelli, R., Koskinen, S., Webster, A. D., Bjorkander, J., Smith, C. I., and Hammarstrom, L. (1995) Family and linkage study of selective IgA deficiency and common variable immunodeficiency. Clin Immunol Immunopathol 77, 185-192.
168. Rada, C., Jarvis, J. M., and Milstein, C. (2002) AID-GFP chimeric protein increases hypermutation of Ig genes with no evidence of nuclear localization. Proc Natl Acad Sci USA 99, 7003-7008.
169. Ito, S., Nagaoka, H., Shinkura, R., Begum, N., Muramatsu, M., Nakata, M., and Honjo, T. (2004) Activation-induced cytidine deaminase shuttles between nucleus and cytoplasm like apolipoproteinB mRNA editing catalytic polypeptide 1. Proc Natl Acad Sci USA 101, 1975-1980.
170. McBride, K. M., Barreto,V., Ramiro, A. R., Stavropoulos, P., and Nussenzweig, M. C. (2004) Somatic hypermutation is limited by CRM1-dependent nuclear export of activation-induced deaminase. J Exp Med 199, 1235-1244.
171. Paine, P. L., Moore, L. C., and Horowitz, S. B. (1975) Nuclear envelope permeability. Nature 254, 109-114.
172. Cattoretti, G., Buttner, M., Shaknovich, R., Kremmer, E., Alobeid, B., and Niedobitek, G. (2006) Nuclear and cytoplasmic AID in extrafollicular and germinal center B cells. Blood 107, 3967-3975.
173. Nagumo, H., Agematsu, K., Kobayashi, N., Shinozaki, K., Hokibara, S., Nagase, H., Takamoto, M., Yasui, K., Sugane, K., and Komiyama, A. (2002) The different process of class switching and somatic hypermutation; a novel analysis by CD27(-) naive B cells. Blood 99, 567-575.
174. Liu,Y. J., Malisan,F., de Bouteiller, O., Guret, C., Lebecque, S., Banchereau, J., Mills,F. C., Max,E. E., and Martinez-Valdez, H. (1996)Within germinal centers, isotype switching ofimmunoglobulin genes occurs after the onset of somatic mutation. Immunity 4, 241-250.
175. Chaudhuri, J., Khuong, C., and Alt, F.W. (2004) Replication protein A interacts with AID to promote deamination of somatic hypermutation targets. Nature 430, 992-998.
176. Sohail, A., Klapacz, J., Samaranayake, M., Ullah, A., and Bhagwat, A. S. (2003) Human activationinduced cytidine deaminase causes transcription-dependent, strand-biased C to U deaminations. Nucleic Acids Res 31, 2990-2994.
177. Bottaro, A., Lansford, R., Xu, L., Zhang, J., Rothman, P., and Alt, F.W. (1994) S region transcription per se promotes basal IgE class switch recombination but additional factors regulate the efficiency of the process. EMBO J 13, 665-674.
178. Betz, A. G., Milstein, C., Gonzalez-Fernandez, A., Pannell, R., Larson,T., and Neuberger,M.S. (1994) Elements regulating somatic hypermutation of an immunoglobulin kappa gene: Critical role for the intron enhancer/matrix attachment region. Cell 77, 239-248.
179. Zhang, J., Bottaro, A., Li, S., Stewart, V., and Alt, F. W. (1993) A selective defect in IgG2b switching as a result of targeted mutation of the I gamma 2b promoter and exon. EMBO J 12, 3529-3537.
180. Jung, S., Rajewsky, K., and Radbruch, A. (1993) Shutdown of class switch recombination by deletion of a switch region control element. Science 259, 984-987.
181. Basu, U., Chaudhuri, J., Alpert, C., Dutt, S., Ranganath, S., Li, G., Schrum, J. P., Manis, J. P., and Alt, F. W. (2005) The AID antibody diversification enzyme is regulated by protein kinaseAphosphorylation. Nature 438, 508-511.
182. Pasqualucci, L., Kitaura, Y., Gu, H., and Dalla-Favera, R. (2006) PKA-mediated phosphorylation regulates the function of activation-induced deaminase (AID) inBcells. Proc Natl Acad Sci USA 103, 395-400.
183. Kuppers, R., and Dalla-Favera, R. (2001) Mechanisms of chromosomal translocations in B cell lymphomas. Oncogene 20, 5580-5594.
184. Pasqualucci, L., Neumeister, P., Goossens, T., Nanjangud, G., Chaganti, R. S.,Kuppers, R., and Dalla-Favera, R. (2001) Hypermutation of multiple proto-oncogenes in B-cell diffuse large-cell lymphomas. Nature 412, 341-346.
185. Rossi, D., Cerri, M., Capello, D., Deambrogi, C., Berra, E., Franceschetti, S., Alabiso, O., Gloghini, A., Paulli, M., Carbone, A., Pileri, S. A., Pasqualucci, L., and Gaidano, G. (2005) Aberrant somatic hypermutation in primary mediastinal large B-cell lymphoma. Leukemia 19, 2363-2366.
186. Gordon, M. S., Kanegai, C. M., Doerr, J. R., andWall, R. (2003) Somatic hypermutation of the B cell receptor genes B29 (Igbeta, CD79b) and mb1 (Igalpha, CD79a). Proc Natl Acad Sci USA 100, 4126-4131.
187. Muschen, M., Re, D., Jungnickel, B., Diehl, V., Rajewsky, K., and Kuppers, R. (2000) Somatic mutation of theCD95gene in humanBcells as a side-effect of the germinal center reaction. J ExpMed 192, 1833-1840.
188. Shen, H. M., Peters, A., Baron, B., Zhu, X., and Storb, U. (1998) Mutation of BCL-6 gene in normal B cells by the process of somatic hypermutation of Ig genes. Science 280, 1750-1752.
189. Pasqualucci, L., Migliazza, A., Fracchiolla, N., William, C., Neri, A., Baldini, L., Chaganti, R. S., Klein, U., Kuppers, R., Rajewsky, K., and Dalla-Favera, R. (1998) BCL-6 mutations in normal germinal centerBcells: Evidence of somatic hypermutation acting outside Ig loci. Proc Natl Acad Sci USA 95, 11816-11821.
190. Ramiro, A. R., Jankovic, M., Callen, E., Difilippantonio, S., Chen, H. T., McBride, K. M., Eisenreich, T. R., Chen, J., Dickins, R. A., Lowe, S. W., Nussenzweig, A., and Nussenzweig, M. C. (2006) Role of genomic instability and p53 in AID-induced c-myc-Igh translocations. Nature 440, 105-109.
191. Duquette,M.L., Pham,P.,Goodman,M.F., and Maizels, N. (2005)AIDbinds to transcription-induced structures in c-MYC that map to regions associated with translocation and hypermutation. Oncogene 24, 5791-5798.
192. Ramiro, A. R., Jankovic, M., Eisenreich, T., Difilippantonio, S., Chen-Kiang, S., Muramatsu, M., Honjo, T., Nussenzweig, A., and Nussenzweig, M. C. (2004) AID is required for c-myc/IgH chromosome translocations in vivo. Cell 118, 431-438.
193. Schreck, S., Buettner, M.,Kremmer, E., Bogdan, M., Herbst, H., and Niedobitek, G. (2006) Activationinduced cytidine deaminase (AID) is expressed in normal spermatogenesis but only infrequently in testicular germ cell tumours. J Pathol 210, 26-31.
194. Muto, T., Okazaki, I. M., Yamada, S., Tanaka, Y., Kinoshita, K., Muramatsu, M., Nagaoka, H., and Honjo, T. (2006) Negative regulation of activation-induced cytidine deaminase in B cells. Proc Natl Acad Sci USA 103, 2752-2757.
195. Okazaki, I. M., Hiai, H., Kakazu, N.,Yamada, S., Muramatsu, M., Kinoshita, K., and Honjo, T. (2003) Constitutive expression of AID leads to tumorigenesis. J Exp Med 197, 1173-1181.
196. Matsumoto, Y., Marusawa, H., Kinoshita, K., Endo, Y., Kou, T., Morisawa, T., Azuma, T., Okazaki, I. M., Honjo, T., and Chiba, T. (2007) Helicobacter pylori infection triggers aberrant expression of activation-induced cytidine deaminase in gastric epithelium. Nat Med 13, 470-476.
197. Endo, Y., Marusawa, H., Kinoshita, K., Morisawa, T., Sakurai, T., Okazaki, I. M., Watashi, K., Shimotohno, K., Honjo,T., and Chiba, T. (2007) Expression of activation-induced cytidine deaminase in human hepatocytes via NF-kappaB signaling. Oncogene 38, 5587-5595 Apr 2, Epub ahead of print.
198. Babbage, G., Ottensmeier, C. H., Blaydes, J., Stevenson, F. K., and Sahota, S. S. (2006) Immunoglobulin heavy chain locus events and expression of activation-induced cytidine deaminase in epithelial breast cancer cell lines. Cancer Res 66, 3996-4000.
199. Jarmuz, A., Chester, A., Bayliss, J., Gisbourne, J., Dunham, I., Scott, J., and Navaratnam, N. (2002)An anthropoid-specific locus of orphan C to U RNA-editing enzymes on chromosome 22. Genomics 79, 285-296.
200. Liao,W., Hong, S. H., Chan, B. H., Rudolph, F. B., Clark, S. C., and Chan, L. (1999) APOBEC-2, a cardiac-and skeletal muscle-specific member of the cytidine deaminase supergene family. Biochem Biophys Res Commun 260, 398-404.
201. Rogozin, I. B., Basu, M. K., Jordan, I. K., Pavlov, Y. I., and Koonin, E. V. (2005) APOBEC4, a new member of the AID/APOBEC family of polynucleotide (deoxy)cytidine deaminases predicted by computational analysis. Cell Cycle 4, 1281-1285.
202. Mikl, M. C.,Watt, I. N., Lu, M., Reik,W., Davies, S. L., Neuberger, M. S., and Rada, C. (2005) Mice deficient in APOBEC2 and APOBEC3. Mol Cell Biol 25, 7270-7277.
203. Harris, R. S., Petersen-Mahrt, S. K., and Neuberger, M. S. (2002)RNAediting enzymeAPOBEC1and some of its homologs can act as DNA mutators. Mol Cell 10, 1247-1253.
204. Fugmann, S. D., Rush, J. S., and Schatz, D. G. (2004) Non-redundancy of cytidine deaminases in class switch recombination. Eur J Immunol 34, 844-849.
205. Iwatani,Y.,Takeuchi, H., Strebel, K., and Levin, J. G. (2006) Biochemical activities of highly purified, catalytically active human APOBEC3G: Correlation with antiviral effect. J Virol 80, 5992-6002.
206. MacDuff, D. A., and Harris, R. S. (2006) DirectedDNAdeamination by AID/APOBEC3 in immunity. Curr Biol 16, R186-189.
207. Wilkins, M. H.F., Stokes, A. R., andWilson, H. R. (1953) Molecular structure of deoxypentose nucleic acids. Nature 171, 738-740.